Multi-omics analysis reveals drivers of loss of β-cell function after newly diagnosed autoimmune type 1 diabetes: An INNODIA multicenter study.
Saved in:
| Title: | Multi-omics analysis reveals drivers of loss of β-cell function after newly diagnosed autoimmune type 1 diabetes: An INNODIA multicenter study. |
|---|---|
| Authors: | Armenteros JJA; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Brorsson C; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Johansen CH; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Banasik K; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Mazzoni G; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Moulder R; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland., Hirvonen K; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland., Suomi T; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland., Rasool O; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland., Bruggraber SFA; Department of Paediatrics, University of Cambridge, Cambridge, England., Marcovecchio ML; Department of Paediatrics, University of Cambridge, Cambridge, England., Hendricks E; Department of Paediatrics, University of Cambridge, Cambridge, England., Al-Sari N; Steno Diabetes Center Copenhagen, Systems Medicine, Herlev, Denmark., Mattila I; Steno Diabetes Center Copenhagen, Systems Medicine, Herlev, Denmark., Legido-Quigley C; Steno Diabetes Center Copenhagen, Systems Medicine, Herlev, Denmark., Suvitaival T; Steno Diabetes Center Copenhagen, Systems Medicine, Herlev, Denmark., Chmura PJ; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Knip M; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Pediatric Research Center, New Children's Hospital, Helsinki University Hospital, Helsinki, Finland., Schulte AM; Bayer Pharmaceuticals, Berlin, Germany., Lee JH; Immunology & Inflammation Research Therapeutic Area, Sanofi, Massachusetts, USA., Sebastiani G; Department of Medicine, Surgery and Neuroscience, Università degli Studi di Siena, Siena, Italy.; Fondazione Umberto di Mario, ONLUS - Toscana Life Sciences, Siena, Italy., Grieco GE; Department of Medicine, Surgery and Neuroscience, Università degli Studi di Siena, Siena, Italy.; Fondazione Umberto di Mario, ONLUS - Toscana Life Sciences, Siena, Italy., Elo LL; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland.; Institute of Biomedicine, University of Turku, Turku, Finland., Kaur S; Steno Diabetes Center Copenhagen, Herlev University Hospital, Herlev, Denmark., Pociot F; Steno Diabetes Center Copenhagen, Herlev University Hospital, Herlev, Denmark., Dotta F; Department of Medicine, Surgery and Neuroscience, Università degli Studi di Siena, Siena, Italy.; Tuscany Centre for Precision Medicine (CReMeP), Siena, Italy., Tree T; Department of Immunobiology, King's College, London, UK., Lahesmaa R; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland., Overbergh L; Department of Chronic Diseases and Metabolism, Endocrinology, Katholieke Universiteit Leuven, Leuven, Belgium., Mathieu C; Department of Chronic Diseases and Metabolism, Endocrinology, Katholieke Universiteit Leuven, Leuven, Belgium., Peakman M; Immunology & Inflammation Research Therapeutic Area, Sanofi, Massachusetts, USA.; Department of Immunobiology, King's College, London, UK., Brunak S; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. |
| Corporate Authors: | INNODIA investigators |
| Source: | Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2024 Jul; Vol. 40 (5), pp. e3833. |
| Publication Type: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883450 Publication Model: Print Cited Medium: Internet ISSN: 1520-7560 (Electronic) Linking ISSN: 15207552 NLM ISO Abbreviation: Diabetes Metab Res Rev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1520-7560 |
|---|---|
| DOI: | 10.1002/dmrr.3833 |
